Correction to: Clinical efficacy of infliximab level and anti-infliximab antibody measurement in patients with inflammat
- PDF / 103,320 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 30 Downloads / 184 Views
CORRECTION
Correction to: Clinical efficacy of infliximab level and anti-infliximab antibody measurement in patients with inflammatory bowel disease: An audit Mihika B. Dave 1 & Alpa J. Dherai 1 & Devendra C. Desai 2 & Bhamini G. Keny 1 & Dhanashri N. Shetty 1 & Satish Kulkarni 3,4 & Kiran Peddi 5 & Tester F. Ashavaid 1
# Indian Society of Gastroenterology 2020
Correction to: Indian Journal of Gastroenterology https://doi.org/10.1007/s12664-020-01050-x The published online version contain error for the author's name “Kiran Peddi” was incorrectly presented as “Kiran Peddy”. The correct presentation is given above.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/ 10.1007/s12664-020-01050-x * Devendra C. Desai [email protected] 1
Department of Biochemistry, P. D. Hinduja Hospital, Veer Savarkar, Marg, Mahim, Mumbai 400 016, India
2
Division of Gastroenterology, P. D. Hinduja Hospital, Veer Savarkar, Marg, Mahim, Mumbai 400 016, India
3
MGM Hospital, Navi Mumbai 402 107, India
4
Apollo Hospital, Navi Mumbai 402 107, India
5
Citizens Specialty Hospital, Hyderabad 500 019, India
Data Loading...
